CN108651777A - 一种甘薯保健饮料及其制备方法 - Google Patents
一种甘薯保健饮料及其制备方法 Download PDFInfo
- Publication number
- CN108651777A CN108651777A CN201710189133.1A CN201710189133A CN108651777A CN 108651777 A CN108651777 A CN 108651777A CN 201710189133 A CN201710189133 A CN 201710189133A CN 108651777 A CN108651777 A CN 108651777A
- Authority
- CN
- China
- Prior art keywords
- parts
- sweet potato
- juice
- fruit
- pears
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 244000017020 Ipomoea batatas Species 0.000 title claims abstract description 88
- 235000002678 Ipomoea batatas Nutrition 0.000 title claims abstract description 88
- 230000036541 health Effects 0.000 title claims abstract description 43
- 235000013361 beverage Nutrition 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 241000220324 Pyrus Species 0.000 claims abstract description 44
- 235000021017 pears Nutrition 0.000 claims abstract description 43
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 40
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 30
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 30
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 29
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 29
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 29
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 29
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 29
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 29
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 29
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 29
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 29
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 29
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 25
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 25
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 25
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 25
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 25
- 239000000796 flavoring agent Substances 0.000 claims abstract description 25
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 25
- 244000241872 Lycium chinense Species 0.000 claims abstract description 22
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 16
- 241000722870 Dicliptera chinensis Species 0.000 claims abstract description 13
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 4
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 15
- 235000015203 fruit juice Nutrition 0.000 claims description 12
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 235000015206 pear juice Nutrition 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 241000220317 Rosa Species 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 235000005979 Citrus limon Nutrition 0.000 claims 1
- 244000131522 Citrus pyriformis Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 206010011224 Cough Diseases 0.000 abstract description 27
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 21
- 210000004072 lung Anatomy 0.000 abstract description 18
- 210000004185 liver Anatomy 0.000 abstract description 17
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 210000001124 body fluid Anatomy 0.000 abstract description 13
- 239000010839 body fluid Substances 0.000 abstract description 13
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 206010000269 abscess Diseases 0.000 abstract description 8
- 230000003712 anti-aging effect Effects 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 230000035922 thirst Effects 0.000 abstract description 7
- 230000036737 immune function Effects 0.000 abstract description 6
- 206010036067 polydipsia Diseases 0.000 abstract description 6
- 238000010791 quenching Methods 0.000 abstract description 6
- 230000004224 protection Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 241001092040 Crataegus Species 0.000 description 26
- 241001570521 Lonicera periclymenum Species 0.000 description 22
- 240000006891 Artemisia vulgaris Species 0.000 description 21
- 239000003814 drug Substances 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 235000013305 food Nutrition 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 description 11
- 208000026435 phlegm Diseases 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 8
- 241000345998 Calamus manan Species 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 240000001987 Pyrus communis Species 0.000 description 7
- 235000014443 Pyrus communis Nutrition 0.000 description 7
- 208000006673 asthma Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 235000012950 rattan cane Nutrition 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229930003944 flavone Natural products 0.000 description 6
- 235000011949 flavones Nutrition 0.000 description 6
- 229930182478 glucoside Natural products 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 244000241838 Lycium barbarum Species 0.000 description 5
- 235000015459 Lycium barbarum Nutrition 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 206010006451 bronchitis Diseases 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000001151 other effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 5
- 235000010894 Artemisia argyi Nutrition 0.000 description 4
- 206010006458 Bronchitis chronic Diseases 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000003266 anti-allergic effect Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 208000007451 chronic bronchitis Diseases 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 208000021760 high fever Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000004904 shortening Methods 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- -1 triterpene glucoside Chemical class 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 241000272520 Aix galericulata Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241001573881 Corolla Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000202807 Glycyrrhiza Species 0.000 description 3
- 244000167230 Lonicera japonica Species 0.000 description 3
- 235000017617 Lonicera japonica Nutrition 0.000 description 3
- 206010025421 Macule Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 244000030166 artemisia Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 206010014599 encephalitis Diseases 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 201000003068 rheumatic fever Diseases 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000207782 Convolvulaceae Species 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000218922 Magnoliophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 241001560086 Pachyrhizus Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 238000003457 Shi epoxidation reaction Methods 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- 208000023819 chronic asthma Diseases 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000005059 dormancy Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 description 1
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000207965 Acanthaceae Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 101710095342 Apolipoprotein B Proteins 0.000 description 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241001435059 Artemisia argyi Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000871264 Cardiospermum halicacabum Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 1
- 101100055841 Danio rerio apoa1 gene Proteins 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000290143 Pyrus x bretschneideri Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241001409321 Siraitia grosvenorii Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- QGXBDMJGAMFCBF-LUJOEAJASA-N epiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-LUJOEAJASA-N 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000003500 flue dust Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229930189775 mogroside Natural products 0.000 description 1
- 229930191869 mogroside IV Natural products 0.000 description 1
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 description 1
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 description 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229930184989 physalin Natural products 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical group 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 1
- XACHQDDXHDTRLX-HZXCUAKRSA-N zeaxanthin dipalmitate Chemical compound CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-HZXCUAKRSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于保健饮料加工技术领域,特别涉及一种甘薯保健饮料及其制备方法,按重量份计,其制备原料包括以下成分:甘薯20‑30份、梨10‑20份、金银花4‑8份、艾草5‑10份、罗汉果8‑18份、狗肝菜6‑12份、甘草5‑10份、山楂4‑8份、枸杞子3‑8份、调味剂1‑5份,本发明具有润肺止咳、生津止渴、清热解毒、凉血利尿、暑热烦渴,咽喉肿痛,促进和调节免疫功能、保肝与抗衰老,有效调节人体微生态平衡与健康的功效。
Description
技术领域
本发明属于保健饮料加工技术领域,特别涉及一种甘薯保健饮料及其制备方法。
背景技术
甘薯,学名:Ipomoea batatas(L.)Lam,又名红薯、白薯、地瓜、番薯等,为旋花科蔓生草本植物,我国很多地区均有栽培和种植。甘薯是薯蔓生出的不定根膨大而成,称之为“块根”,按皮色区分为红白两型,按肉色可分为白、黄、杏黄、桔红四色,甘薯通常被蒸熟后鲜食,常见的加工制品有熟制,熟制后凉干或烘干,也被用于制造淀粉和粉条,或作为酿酒的原料。随着对甘薯营养保健功能认识的增加,甘薯及其制品越来越受到人们的重视和欢迎。甘薯营养丰富,其含有的蛋白质、脂肪、碳水化合物、无机盐与谷物粮食相差不大,尚含有一些B族维生素、维生素C和胡萝卜素等营养素。甘薯中所含的蛋白质虽不高,但所含粘蛋白的比例较高,粘蛋白是一种多糖与蛋白质的混合物,其主要作用是防止脂肪在血管壁上的沉积并保持消化道和关节腔的润滑作用;近年来,科学家发现,甘薯中含有一种称之去表雄酮的化学物质对多种癌症有防治作用;甘薯中含有丰富而细嫩纤维素,由于纤维素的结构中含有很多亲水基团,使之具有很强的持水性,可刺激肠道蠕动而促进排便;甘薯食后在体内的代谢产物呈碱性,可中和由于食用肉、蛋等酸性食品产生的酸性物质,从而有利于维持体内的酸碱平衡;甘薯水分含量多,体积大,食后有饱腹感,不易造成过食,因而也是一种理想的减肥食品。现代医学证明甘薯具有多种保健功能,并将其称之“长寿食品”。
目前,日益增长的生活工作压力使人们体力和脑力透支,随着生活水平的提高,人们对于健康的要求越来越高,大家更多地借助于食品和药品减轻疲劳,提高免疫力,提高睡眠质量,因此人们需要更多的功能性保健品。
发明内容
本发明的目的在于:针对上述存在的问题,本发明提供了一种甘薯保健饮料及其制备方法,具有润肺止咳、生津止渴、清热解毒、凉血利尿、暑热烦渴,咽喉肿痛,促进和调节免疫功能、保肝与抗衰老,有效调节人体微生态平衡与健康的功效。
本发明的技术方案为:
本发明的甘薯保健饮料,按重量份计,其制备原料包括以下成分:甘薯20-30份、梨10-20份、金银花4-8份、艾草5-10份、罗汉果8-18份、狗肝菜6-12份、甘草5-10份、山楂4-8份、枸杞子3-8份、调味剂1-5份。
优选的,本发明的甘薯保健饮料,按重量份计,其制备原料包括以下成分:甘薯25份、梨15份、金银花7份、艾草8份、罗汉果10份、狗肝菜10份、甘草7份、山楂5份、枸杞子6份、调味剂4份。
优选的,所述调味剂包括:白糖、柠檬酸和玫瑰香料其中的一种或者多种。
优选的,本发明的甘薯保健饮料的制备方法,包括以下步骤:
(1)按重量份配比准备好原料;
(2)分别将新鲜的甘薯和梨用清水洗去泥沙,然后清洗干净,分别去皮,梨去核,切碎榨汁,按1∶1加入清水榨汁,所得汁液通过离心分离得到的甘薯汁和梨的果汁,备用;
(3)将金银花、艾草、罗汉果、甘草、山楂、枸杞子晒干、磨碎,放入90~100℃水中浸泡30~40分钟过滤获得提取液;
(4)分别将步骤(2)所得的甘薯汁和梨汁的果汁加入到步骤(3)所得提取液混合均匀,加热到80~100℃的水中浸泡5~20分钟,均匀搅拌,得到混合物汁液,冷却至室温;
(5)将步骤(4)所得混合物汁液置于60~80℃下杀菌30~40分钟,待自然冷至室温,瓶装,得到保健饮料。
优选的,所述步骤(3)中放入95℃水中浸泡35分钟过滤获得提取液。
上述技术方案中:
甘薯,又名红薯、白薯、地瓜、番薯等,为旋花科蔓生草本植物,我国很多地区均有栽培和种植。甘薯是薯蔓生出的不定根膨大而成,称之为“块根”,按皮色区分为红白两型,按肉色可分为白、黄、杏黄、桔红四色,甘薯通常被蒸熟后鲜食,常见的加工制品有熟制,熟制后凉干或烘干,也被用于制造淀粉和粉条,或作为酿酒的原料。甘薯营养丰富,其含有的蛋白质、脂肪、碳水化合物、无机盐与谷物粮食相差不大,尚含有一些B族维生素、维生素C和胡萝卜素等营养素。近年来,科学家发现,甘薯中含有一种称之去表雄酮的化学物质对多种癌症有防治作用;甘薯中含有丰富而细嫩纤维素,由于纤维素的结构中含有很多亲水基团,使之具有很强的持水性,可刺激肠道蠕动而促进排便;甘薯食后在体内的代谢产物呈碱性,可中和由于食用肉、蛋等酸性食品产生的酸性物质,从而有利于维持体内的酸碱平衡;甘薯水分含量多,体积大,食后有饱腹感,不易造成过食,因而也是一种理想的减肥食品。现代医学证明甘薯具有多种保健功能,并将其称之“长寿食品”。生甘薯汁能中和体内因过多食用肉食和蛋类所产生的守多的酸,保持人体酸碱平衡,甘薯含有较多的纤维素,能吸收胃肠中较多的水分,润滑消化道,起通便作用,并可将肠道内过多的脂肪、糖、毒素排出体外,起到降脂作用。
梨:拉丁学名:Pyrus spp,别称:大鸭梨,二名法鸭梨,植物界,被子植物门,门被子植物,分布区域河南、河北、山东、辽宁、江苏、四川、云南、新疆等。梨树根系发达,垂直根深可达2-3m以上,水平根分布较广,约为冠幅2倍左右。喜光喜温,宜选择土层深厚、排水良好的缓坡山地种植,尤以砂质壤土山地为理想。干性强,层性较明显。结果早,结果期长,有些品种2-3年即开始结果,盛果期可维持50年以上,性味:味甘、微酸、性寒、无毒。梨味甘微酸、性凉,入肺、胃经;具有生津、润燥、清热、化痰,解酒的作用;用于热病伤阴或阴虚所致的干咳、口渴、便秘等症,也可用于内热所致的烦渴、咳喘、痰黄等症。梨果:生津、润燥、清热、化痰等功效,适用于热病伤津烦渴、消渴症、热咳、痰热惊狂、噎膈、口渴失音、眼赤肿痛、消化不良。主治热嗽,止咳。治咳热,中风不语,伤寒发热,解丹石热气,惊邪。利大小便,除贼风,止心烦气喘热狂。润肺凉心,消痰降炎,解 疮毒、酒毒。具有下火,治便秘功效。梨除可供生食外,还可酿酒、制梨膏、梨脯,以及药用。如梨果治热咳,切片贴之治火伤;捣汁内,润肺凉心,解疮毒、酒毒。梨花能去面黑粉刺;梨叶煎服,治风 和小儿寒疝,树皮能除结气咳逆等症。食用价值:梨果鲜美,肉脆多汁,酸甜可口,风味芳香优美。富含糖、蛋白质、脂肪、碳水化合物及多种维生素,对人体健康有重要作用。梨子具有清肺养肺的作用。多吃梨的人远比不吃或少吃梨的人感冒机率要低,所以有科学家和医师把梨称为“全方位的健康水果”或“全科医生”。由于社会发展空气污染比较严重,梨可改善呼吸系统和肺功能,有润肺的功效,可以降低肺部受空气中的灰尘和烟尘的影响。梨果还可以加工制作梨干、梨脯、梨膏、梨汁、梨罐头等,也可用来酿酒、制醋。梨果还有医用价值,可助消化、润肺清心,消痰止咳、退热、解毒疮的功效,还有利尿、润便的作用。梨木细致,软硬适度,是雕刻印章和高级家具的原料。梨的含糖量在15%以下,每天的食用量可在300-500克,糖尿病人可以食用。梨肉脆汁多、酸甜可口,营养丰富,有益健康。具有降低感冒几率;保护心脏;增进食欲;清热镇静;防癌抗癌;消除便秘;预防骨质疏松之功效作用。
金银花:中文学名:忍冬,拉丁学名:Lonicera japonica Thunb,别称: 金银藤、银藤、二色花藤、二宝藤、右转藤、子风藤、鸳鸯藤、二花,由于忍冬花初开为白色,后转为黄色,因此得名金银花,忍冬科,忍冬属,三月开花,五出,微香,蒂带红色,花初开则色白,经一、二日则色黄,故名金银花。又因为一蒂二花,两条花蕊探在外,成双成对,形影不离,状如雄雌相伴,又似鸳鸯对舞,故有鸳鸯藤之称。金银花甘寒清热而不伤胃,芳香透达又可祛邪,自古被誉为清热解毒的良药。金银花既能宣散风热,还善清解血毒。金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。现代研究证明,金银花含有绿原酸、木犀草素苷等药理活性成分,对溶血性链球菌、金黄葡萄球菌等多种致病菌及上呼吸道感染致病病毒等有较强的抑制力,另外还可增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血(凝血)、抑制肠道吸收胆固醇等,其临床用途非常广泛,可与其它药物配伍用于治疗呼吸道感染、菌痢、急性泌尿系统感染、高血压等40余种病症。具有抗病原微生物;抗炎和解热;加强免疫机能作用;中枢兴奋;降血脂作用;抗内毒素之功效。
艾草,学名:Artemisia argyi H.Lév. & Vaniot,别名:萧茅、冰台、遏草、香艾、蕲艾、艾萧、艾蒿、艾蒿、蓬藁、艾﹑灸草﹑医草﹑黄草﹑艾绒等。多年生草本或略成半灌木状,植株有浓烈香气。茎单生或少数,褐色或灰黄褐色,基部稍木质化,上部萆质,并有少数短的分枝,叶厚纸质,上面被灰白色短柔毛,基部通常无假托叶或极小的假托叶,上部叶与苞片叶羽状半裂、头状花序椭圆形,花冠管状或高脚杯状,外面有腺点,花药狭线形,花柱与花冠近等长或略长于花冠。瘦果长卵形或长圆形。花果期9-10月。全草入药,有温经、去湿、散寒、止血、消炎、平喘、止咳、安胎、抗过敏等作用。艾叶晒干捣碎得“艾绒”,制艾条供艾灸用,又可作“印泥”的原料。入药,性温、苦、辛、微甘。历代医籍记载为“止血要药”,又是妇科常用药之一,治虚寒性的妇科疾患尤佳,又治老年慢性支气管炎与哮喘,煮水洗浴时可防治产褥期母婴感染疾病,或制药枕头、药背心,防治老年慢性支气管炎或哮喘及虚寒胃痛等;此外全草作杀虫的农药或薰烟作房间消毒、杀虫药。嫩芽及幼苗作菜蔬。艾草性味苦、辛、温,入脾、肝、肾。艾以叶入药,性温、味苦、无毒、纯阳之性、通十二经、具回阳、理气血、逐湿寒、止血安胎等功效,亦常用于针灸。艾草有调经止血﹑安胎止崩﹑散寒除湿之效。治月经不调、经痛腹痛﹑流产﹑子宫出血,根治风湿性关节炎﹑头风﹑月内风等。因它可削冰令圆,又可炙百病,为医家最常用之药。现代实验研究证明,艾叶具有抗菌及抗病毒作用;平喘、镇咳及祛痰作用;止血及抗凝血作用;镇静及抗过敏作用;护肝利胆作用等。艾草可作“艾叶茶”、“艾叶汤”、“艾叶粥”等食谱,以增强人体对疾病的抵抗能力。艾草具有一种特殊的香味,这特殊的香味具有驱蚊虫的功效,所以,古人常在门前挂艾草,一来用于避邪,二来用于赶走蚊虫。
罗汉果,拉丁学名:Siraitia grosvenorii,别名:拉汗果、假苦瓜、光果木鳖、金不换、罗汉表、裸龟巴,葫芦科多年生藤本植物的果实。被人们誉为神仙果,其叶心形,雌雄异株,夏季开花,秋天结果。主要产于广西壮族自治区桂林市永福县龙江乡、龙胜和百寿等镇,其中永福种植罗汉果已经有300多年历史,中国百分之九十罗汉果产于永福县和龙胜县。攀援草本;根多年生,肥大,纺锤形或近球形;茎、枝稍粗壮,有棱沟,初被黄褐色柔毛和黑色疣状腺鳞,后毛渐脱落变近无毛。叶柄长3-10厘米,被同枝条一样的毛被和腺鳞;叶片膜质,卵形心形、三角状卵形或阔卵状心形,罗汉果甘、酸、性凉,归肺、大肠经,有清热凉血、生津止咳、滑肠排毒、嫩肤益颜、润肺化痰等功效,果实营养价值很高,含丰富的维生素C以及糖甙、果糖、葡萄糖、蛋白质和脂类等,可用于益寿延年、驻颜悦色及治疗痰热咳嗽、咽喉肿痛、大便秘结、消渴烦躁诸症此外还有润肠通便的功效。罗汉果含罗汉果甙,较蔗糖甜300倍;另含果糖、氨基酸、黄酮等。果中含非糖甜味的成分,主要是三萜甙类:罗汉果甙Ⅴ及Ⅳ,甙Ⅴ的甜度是蔗糖的256~344倍,甙Ⅳ的甜度为蔗糖的126倍,还含大量葡萄糖,果糖占14%。含锰、铁、镍、硒、锡、碘、钼等26种无机元素、蛋白质、维生素C等。罗汉果的果实和和叶均含有罗汉果三萜皂苷,还有大量的果糖、十多种人体必需氨基酸、脂肪酸、黄酮类化合物、维生素C、微量元素等。罗汉果皂苷作为罗汉果甜味剂的主要成分,是一种具有甜味的三萜烯葡萄糖苷,其配糖苷元是三萜烯醇。罗汉果干果中富含蛋白质。在其水解物中,除色氨酸未被测定外,18种氨基酸齐全。在测定的氨基酸中,含量较高的有谷氨酸、天冬氨酸、缬氨酸、丙氨酸和亮氨酸。谷氨酸是人体中需要量最大的非必需氨基酸,是合成谷胱甘肽的重要原料,可见罗汉果具有较高的营养价值。罗汉果果实中含有24种无机元素,其中人体必需的微量元素和广泛元素有16种,含量较高的元素有钾、钙和镁。罗汉果中含有的硒达到0.186mg/kg,是粮食的2~4倍,而元素硒在冠心病防治、抗衰老、抗癌方面有较好的疗效。罗汉果为卫生部首批公布的药食两用名贵中药材,不产生热量,是饮料、糖果行业的名贵原料,是蔗糖的最佳替代品。常饮罗汉果茶,可防多种疾病,现代医学证明,罗汉果对支气管炎、高血压等疾病有显著疗效,还是起到防治冠心病、血管硬化以及肥胖症的作用。营养价值高,有清热解暑、化痰止咳、凉血舒骨、清肺润肠和生津止渴等功效;可治咽喉炎、支气管哮喘、百日咳、胃热、便秘、急性扁桃体炎等症,糖尿病患者亦宜服用。
狗肝菜,拉丁名:Dicliptera chinensis (L.)Juss,别称:四籽马蓝、华九头,路边青,狮子草,植物界,被子植物门,双子叶植物纲,合瓣花亚纲,管状花目,爵床科, 性味归经:苦,寒。入心、肾二经,甘、淡,凉。清热解毒,凉血生津,利尿。具有清热解毒、凉血、生津、利尿作用的功效;用于感冒高热,斑疹发热,暑热烦渴,乙脑,风湿关节痛,咽喉肿痛,目赤,小便不利;外用于疖肿,缠腰火丹。用治实热内结之热毒斑疹、便血、小便不利、肿毒疔疮等症;外用可用治跌打损伤、红肿出血。
甘草,拉丁学名:Glycyrrhiza uralensis Fisch,别名:国老、甜草、乌拉尔甘草、甜根子。豆科、甘草属多年生草本,根与根状茎粗壮,是一种补益中草药。对人体很好的一种药,药用部位是根及根茎,药材性状根呈圆柱形,长25~100厘米,直径0.6~3.5厘米。外皮松紧不一,表面红棕色或灰棕色。根茎呈圆柱形,表面有芽痕,断面中部有髓。气微,味甜而特殊。喜阴暗潮湿,日照长气温低的干燥气候。甘草多生长在干旱、半干旱的荒漠草原、沙漠边缘和黄土丘陵地带。根和根状茎供药用。性味甘平,归心、肺、脾、胃经。具补脾益气、润肺止咳、缓急止痛、缓和药性之功,其有效成分为甘草甜素、甘草次酸、甘草苷元、甘草多糖。功能主治清热解毒、祛痰止咳、脘腹等。用于治疗心气虚,心悸怔忡,脉结代,脾胃气虚;痈疽疮疡、咽喉肿痛,气喘咳嗽,胃痛、腹痛以及腓肠肌挛急疼痛等。
山楂,拉丁文名:Crataegus pinnatifida Bunge,又名山里果、山里红,蔷薇科,山楂属,落叶乔木,高可达6米。核果类水果,核质硬,果肉薄,味微酸涩。具有降血脂、血压、强心、抗心律不齐等作用,同时也是健脾开胃、消食化滞、活血化痰的良药,对胸膈脾满、疝气、血淤、闭经等症有很好的疗效。山楂内的黄酮类化合物牡荆素,是一种抗癌作用较强的药物,其提取物对抑制体内癌细胞生长、增殖和浸润转移均有一定的作用。山楂含多种有机酸。口服后增强胃液酸度,提高胃蛋白酶活性,促进蛋白质的消化;山楂味酸,刺激胃黏膜促进胃液分泌;山楂中含脂肪酶,能促进脂肪的消化;降血脂、抗动脉粥样硬化,山楂内含的黄酮可显著降低实验性高血脂动物的血清总胆固醇、低密度脂蛋白胆固醇和载脂蛋白B的浓度,显著升高高密度脂蛋白一胆固醇和载脂蛋白A的浓度,但对甘油三酯影响不大。山楂降血脂作用是通过抑制肝脏胆固醇的合成,促进肝脏对血浆胆固醇的摄人而发挥降血脂作用。山楂黄酮还可降低动脉粥样硬化发生的危险性,且起到预防发生发展的作用。对抗心肌缺血,急性实验性心肌缺血具有保护作用。山楂黄酮、水解产物增加缺血心肌营养性血流量,其中以山楂水解产物作用最强。山楂在增加冠状动脉血流量的同时,还能降低心肌耗氧量,提高氧利用率。山楂黄酮具有改善动物的缺血心电图作用。
枸杞子,外文名:FRUCTUS LYCII,别称:甜菜子,红耳坠,地骨子,地骨皮,为茄科植物枸杞的成熟果实。夏、秋果实成熟时采摘,除去果柄,置阴凉处晾至果皮起皱纹后,再暴晒至外皮干硬、果肉柔软即得。遇阴雨可用微火烘干。是卫生部批准的药食两用食物。适量食用有益健康,配合菊杞茶有清肝明目的效果。《神农本草经》中就被列为上品,称其为“久服轻身不老、耐寒暑”;性味:甘,平,归经:归肝、肾经,功能主治:滋补肝肾,益精明目,用于肝肾阴虚证 本品甘平质润,平补肝肾,有滋补强壮作用,凡肝肾阴虚诸证均可应用。有延衰抗老的功效,枸杞子中含有多种氨基酸,并含有甜菜碱、玉蜀黍黄素、酸浆果红素等特殊营养成分,使其具有非常好的保健功效。适合所有人食用。枸杞子含有丰富的胡萝卜素,维生素A、维生素B、维生素B、维生素C以及钙、铁等有益眼睛的必需营养,有良好的明目作用,所以俗称“明眼子”。历代医家治疗肝血不足、肾阴亏虚引起的视物昏花和夜盲症,常常使用枸杞子。枸杞子含有β一胡萝b素、叶黄素等,具有提高人体免疫功能、防止肿瘤形成及预防动脉粥样硬化等作用。枸杞的营养成分丰富,是当今营养全面的天然原料。枸杞子中含有大量的蛋白质、氨基酸、维生素和铁、锌、磷、钙等人体必需的营养成分,有促进和调节免疫功能、保肝和抗衰老三大药理作用,具有不可代替的药用价值。枸杞多糖是枸杞中最重要最关键的成分之一,能促进腹腔巨噬细胞的吞噬能力,对人体具有改善新陈代谢、调节内分泌、促进蛋白质合成、加速肝脏解毒和受损肝细胞的修复,抑制胆固醇和甘油三酯的功能,并且对肝脏的脂质过氧化损伤有明显的保护和修复作用。可调节机体免疫功能、能有效抑制肿瘤生长和细胞突变、具有延缓衰老、抗脂肪肝、调节血脂和血糖、促进造血功能等方面的作用,并应用于临床。
与现有技术相比,本发明突出的实质性特点和显著的进步是:
本发明主要以甘薯为主要原料,生甘薯汁能中和体内因过多食用肉食和蛋类所产生的守多的酸,保持人体酸碱平衡,甘薯含有较多的纤维素,能吸收胃肠中较多的水分,润滑消化道,起通便作用,并可将肠道内过多的脂肪、糖、毒素排出体外,起到降脂作用,且以梨、金银花、艾草、罗汉果、狗肝菜、甘草、山楂以及枸杞子作为辅助药材,在这些辅助药材中,梨具有生津、润燥、清热、化痰等功效;金银花有清热解毒、疏利咽喉、消暑除烦的作用;罗汉果具有润肺止咳、生津止渴的作用;艾草具有抗菌及抗病毒,平喘、镇咳及祛痰,止血及抗凝血,镇静及抗过敏,护肝利胆作用;狗肝菜具有清热解毒、凉血、生津、利尿作用的功效,用于治疗感冒高热,斑疹发热,暑热烦渴,乙脑,风湿关节痛,咽喉肿痛等;甘草含有甘草甜素、甘草次酸、甘草多糖等多种化学成分,具有抗炎及抗变态反应作用,可调节机体免疫功能,抗肿瘤,止痛,和中缓急,润肺,解毒,调和诸药等,可使其他药材发挥到最大的作用;山楂具有降血脂防治心血管疾病,降低血压和胆固醇、软化血管及利尿、开胃消食活血化瘀,抗衰老的作用;枸杞子有滋补强壮,促进和调节免疫功能、保肝与抗衰老作用,以上各方相辅相成,互为补缺调和,让药方的作用发挥到极致。而且由于本发明配方中新鲜的梨汁,以及甜味素极高的罗汉果,其甘甜的味道很容易被人们所接受,且添加了调味剂,解决了药物以往苦涩难以喝下的缺陷,这样,不但成年人可服用,本方也适合于少年儿童人群的饮用,同时也能让人们长期坚持调养,长期食用,能够达到润肺止咳、生津止渴、清热解毒、凉血利尿、暑热烦渴,治疗咽喉肿痛,促进和调节免疫功能、保肝与抗衰老,有效调节人体微生态平衡与健康,本发明中各个组分作用相辅相成,达到最好的保健效果。
具体实施方式
下面结合具体的实施例对本发明做进一步说明:
实施例1
本发明的甘薯保健饮料,按重量份计,其制备原料包括以下成分:甘薯20份、梨18份、金银花8份、艾草5份、罗汉果12份、狗肝菜10份、甘草10份、山楂4份、枸杞子7份、调味剂5份。
本实施例中,所述调味剂包括白糖和玫瑰香料。
本实施例中,甘薯保健饮料的制备方法,包括以下步骤:
(1)按重量份配比准备好原料;
(2)分别将新鲜的甘薯和梨用清水洗去泥沙,然后清洗干净,分别去皮,梨去核,切碎榨汁,按1∶1加入清水榨汁,所得汁液通过离心分离得到的甘薯汁和梨的果汁,备用;
(3)将金银花、艾草、罗汉果、甘草、山楂、枸杞子晒干、磨碎,放入90℃水中浸泡40分钟过滤获得提取液;
(4)分别将步骤(2)所得的甘薯汁和梨汁的果汁加入到步骤(3)所得提取液混合均匀,加热到90℃的水中浸泡20分钟,均匀搅拌,得到混合物汁液,冷却至室温;
(5)将步骤(4)所得混合物汁液置于60℃下杀菌40分钟,待自然冷至室温,瓶装,得到保健饮料。
实施例2
本发明的甘薯保健饮料,按重量份计,其制备原料包括以下成分:甘薯30份、梨12份、金银花6份、艾草8份、罗汉果15份、狗肝菜6份、甘草6份、山楂5份、枸杞子5份、调味剂2份。
本实施例中,所述调味剂包括柠檬酸和玫瑰香料。
本实施例中,本发明的甘薯保健饮料的制备方法,包括以下步骤:
(1)按重量份配比准备好原料;
(2)分别将新鲜的甘薯和梨用清水洗去泥沙,然后清洗干净,分别去皮,梨去核,切碎榨汁,按1∶1加入清水榨汁,所得汁液通过离心分离得到的甘薯汁和梨的果汁,备用;
(3)将金银花、艾草、罗汉果、甘草、山楂、枸杞子晒干、磨碎,放入100℃水中浸泡30分钟过滤获得提取液;
(4)分别将步骤(2)所得的甘薯汁和梨汁的果汁加入到步骤(3)所得提取液混合均匀,加热到100℃的水中浸泡10分钟,均匀搅拌,得到混合物汁液,冷却至室温;
(5)将步骤(4)所得混合物汁液置于80℃下杀菌30分钟,待自然冷至室温,瓶装,得到保健饮料。
实施例3
本发明的甘薯保健饮料,按重量份计,其制备原料包括以下成分:甘薯25份、梨15份、金银花7份、艾草8份、罗汉果10份、狗肝菜10份、甘草7份、山楂5份、枸杞子6份、调味剂4份。
本实施例中,所述调味剂包括白糖、柠檬酸和玫瑰香料。
本实施例中,本发明的甘薯保健饮料的制备方法,包括以下步骤:
(1)按重量份配比准备好原料;
(2)分别将新鲜的甘薯和梨用清水洗去泥沙,然后清洗干净,分别去皮,梨去核,切碎榨汁,按1∶1加入清水榨汁,所得汁液通过离心分离得到的甘薯汁和梨的果汁,备用;
(3)将金银花、艾草、罗汉果、甘草、山楂、枸杞子晒干、磨碎,放入98℃水中浸泡38分钟过滤获得提取液;
(4)分别将步骤(2)所得的甘薯汁和梨汁的果汁加入到步骤(3)所得提取液混合均匀,加热到100℃的水中浸泡15分钟,均匀搅拌,得到混合物汁液,冷却至室温;
(5)将步骤(4)所得混合物汁液置于70℃下杀菌35分钟,待自然冷至室温,瓶装,得到保健饮料。
实施例4
本发明的甘薯保健饮料,按重量份计,其制备原料包括以下成分:甘薯28份、梨16份、金银花6份、艾草5份、罗汉果8份、狗肝菜8份、甘草9份、山楂7份、枸杞子8份、调味剂3份。
本实施例中,所述调味剂包括白糖和玫瑰香料。
本实施例中,本发明的甘薯保健饮料的制备方法,包括以下步骤:
(1)按重量份配比准备好原料;
(2)分别将新鲜的甘薯和梨用清水洗去泥沙,然后清洗干净,分别去皮,梨去核,切碎榨汁,按1∶1加入清水榨汁,所得汁液通过离心分离得到的甘薯汁和梨的果汁,备用;
(3)将金银花、艾草、罗汉果、甘草、山楂、枸杞子晒干、磨碎,放入95℃水中浸泡35分钟过滤获得提取液;
(4)分别将步骤(2)所得的甘薯汁和梨汁的果汁加入到步骤(3)所得提取液混合均匀,加热到95℃的水中浸泡18分钟,均匀搅拌,得到混合物汁液,冷却至室温;
(5)将步骤(4)所得混合物汁液置于75℃下杀菌40分钟,待自然冷至室温,瓶装,得到保健饮料。
针对本发明的疗效,下面通过临床治疗效果对本发明的甘薯保健饮料作进一步验证:
1.毒性试验:
取家兔4只,家犬4只为试验对象,分为四组,其中:第Ⅰ组为2只家兔;第Ⅱ组为2只家兔;第Ⅲ组为2只家犬;第Ⅳ组为2只家犬,对第Ⅰ组和第Ⅱ组的兔、犬每天以人的剂量1g/50kg的20倍灌胃;第Ⅱ组和第Ⅲ组按正常喂养,时间为一个月。结果第Ⅰ组和第Ⅱ组无明显毒性反应,对呼吸、血压、尿量均无影响,表现与其它两组的家兔和家犬一样。
2.临床治疗效果试验:
蒙某,男,75岁,广西南宁市兴宁区人,慢性支气管炎,咳嗽不止,风湿关节痛,感觉浑身无力,睡眠不好,耳鸣心悸,腰膝酸软,服用本发明的甘薯保健饮料3个月,风湿关节痛症状减轻,耳鸣心悸、腰膝酸软痊愈和咳嗽现象消失,慢性支气管炎痊愈,目前身体状况良好,睡眠质量很好。
黄某,女,7岁,广西全州人,感冒高热,发烧39.3°,咳嗽不止,咽喉肿痛,服用本发明的甘薯保健饮料3天,高烧退至37.5°,咳嗽有所好转,继续服用9天,以上症状消失,精神状态良好,体温恢复正常,可上学。
郑某,女,30岁,广西南宁市人,身高1.63m ,体重70kg,因感觉自己肥胖,刻意减肥,造成营养不良,脸上苍白,食欲不佳,晚上口渴,起来数次,睡眠不好,服用本发明的甘薯保健饮料1个月,食欲恢复正常,口渴现象消失,睡眠有所改善,继续服用3个月,以上症状消失,体重66kg,脸上红润,工作精力充沛。
陆某,男,55岁,广西南宁市西乡塘区人,高企领导,工作压力大,感冒咳嗽,暑热烦渴,晚上多次起床喝水,严重影响睡眠质量,感觉身心疲惫,全身无力,服用本发明人的甘薯保健饮料,服用3天后感冒好转,各症状减轻,继续服用1个月,以上症状全部消失,精神状态良好。
农某,男,13岁,广西兴安人,咳嗽不止,肺部轻度感染,脸色苍白,睡眠质量不好,经服用本发明的甘薯保健饮料1个月,睡眠质量大大改善,咳嗽痊愈,脸色红润,身体健康。
李某,女,23岁,广西柳州市人,感冒发热,脸上出现斑疹,失眠头痛,腹胀不思进食,口干舌燥,大便干结,服用本发明的甘薯保健饮料2个月,以上各症状消失,食欲恢复,大便正常,工作精力充沛。
Claims (5)
1.一种甘薯保健饮料,其特征在于:按重量份计,其制备原料包括以下成分:甘薯20-30份、梨10-20份、金银花4-8份、艾草5-10份、罗汉果8-18份、狗肝菜6-12份、甘草5-10份、山楂4-8份、枸杞子3-8份、调味剂1-5份。
2.根据权利要求1所述的一种甘薯保健饮料,其特征在于:按重量份计,其制备原料包括以下成分:甘薯25份、梨15份、金银花7份、艾草8份、罗汉果10份、狗肝菜10份、甘草7份、山楂5份、枸杞子6份、调味剂4份。
3.根据权利要求1所述的一种甘薯保健饮料,其特征在于:所述调味剂包括:白糖、柠檬酸和玫瑰香料其中的一种或者多种。
4.如权利要求1-3任意一项所述的一种甘薯保健饮料的制备方法,其特征在于:包括以下步骤:
(1)按重量份配比准备好原料;
(2)分别将新鲜的甘薯和梨用清水洗去泥沙,然后清洗干净,分别去皮,梨去核,切碎榨汁,按1∶1加入清水榨汁,所得汁液通过离心分离得到的甘薯汁和梨的果汁,备用;
(3)将金银花、艾草、罗汉果、甘草、山楂、枸杞子晒干、磨碎,放入90~100℃水中浸泡30~40分钟过滤获得提取液;
(4)分别将步骤(2)所得的甘薯汁和梨汁的果汁加入到步骤(3)所得提取液混合均匀,加热到80~100℃的水中浸泡5~20分钟,均匀搅拌,得到混合物汁液,冷却至室温;
(5)将步骤(4)所得混合物汁液置于60~80℃下杀菌30~40分钟,待自然冷至室温,瓶装,得到保健饮料。
5.根据权利要求4所述的一种甘薯保健饮料的制备方法,其特征在于:所述步骤(3)中放入95℃水中浸泡35分钟过滤获得提取液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710189133.1A CN108651777A (zh) | 2017-03-27 | 2017-03-27 | 一种甘薯保健饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710189133.1A CN108651777A (zh) | 2017-03-27 | 2017-03-27 | 一种甘薯保健饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108651777A true CN108651777A (zh) | 2018-10-16 |
Family
ID=63786386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710189133.1A Withdrawn CN108651777A (zh) | 2017-03-27 | 2017-03-27 | 一种甘薯保健饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108651777A (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1410012A (zh) * | 2002-11-22 | 2003-04-16 | 湖南省原子能农业应用研究所 | 紫甘薯保健饮料及生产方法 |
CN102972821A (zh) * | 2012-11-08 | 2013-03-20 | 沈阳信达信息科技有限公司 | 一种梨汁饮料的制作方法 |
CN105105256A (zh) * | 2015-07-22 | 2015-12-02 | 邓绍祥 | 富氢保健饮料及其制备方法 |
CN105142428A (zh) * | 2013-02-28 | 2015-12-09 | Swm卢森堡有限公司 | 用于制造茶饮料或草本和蔬菜汤的组合物 |
CN105558682A (zh) * | 2015-12-08 | 2016-05-11 | 哈尔滨溪泉饮料有限公司 | 具有清嗓功能的山楂饮料及制作方法 |
CN106107427A (zh) * | 2016-06-21 | 2016-11-16 | 吴花 | 一种姜汁制品以及用途 |
CN106261380A (zh) * | 2016-08-16 | 2017-01-04 | 安徽省王巢食品有限公司 | 一种玫瑰花保健饮料及其制作方法 |
CN106333186A (zh) * | 2016-08-19 | 2017-01-18 | 山东省食品发酵工业研究设计院 | 一种甘薯饮料的制备方法 |
KR20170017218A (ko) * | 2015-08-06 | 2017-02-15 | 경남대학교 산학협력단 | 청포도, 미나리, 및 비트를 함유하는 항노화 기능성 과채음료 및 이의 제조방법 |
-
2017
- 2017-03-27 CN CN201710189133.1A patent/CN108651777A/zh not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1410012A (zh) * | 2002-11-22 | 2003-04-16 | 湖南省原子能农业应用研究所 | 紫甘薯保健饮料及生产方法 |
CN102972821A (zh) * | 2012-11-08 | 2013-03-20 | 沈阳信达信息科技有限公司 | 一种梨汁饮料的制作方法 |
CN105142428A (zh) * | 2013-02-28 | 2015-12-09 | Swm卢森堡有限公司 | 用于制造茶饮料或草本和蔬菜汤的组合物 |
CN105105256A (zh) * | 2015-07-22 | 2015-12-02 | 邓绍祥 | 富氢保健饮料及其制备方法 |
KR20170017218A (ko) * | 2015-08-06 | 2017-02-15 | 경남대학교 산학협력단 | 청포도, 미나리, 및 비트를 함유하는 항노화 기능성 과채음료 및 이의 제조방법 |
CN105558682A (zh) * | 2015-12-08 | 2016-05-11 | 哈尔滨溪泉饮料有限公司 | 具有清嗓功能的山楂饮料及制作方法 |
CN106107427A (zh) * | 2016-06-21 | 2016-11-16 | 吴花 | 一种姜汁制品以及用途 |
CN106261380A (zh) * | 2016-08-16 | 2017-01-04 | 安徽省王巢食品有限公司 | 一种玫瑰花保健饮料及其制作方法 |
CN106333186A (zh) * | 2016-08-19 | 2017-01-18 | 山东省食品发酵工业研究设计院 | 一种甘薯饮料的制备方法 |
Non-Patent Citations (1)
Title |
---|
叶强: "《中国食疗本草新编》", 30 September 1999 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106889233A (zh) | 一种袋泡参苓白术茶及其制备方法 | |
CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
CN107094974A (zh) | 一种黑枸杞保健糖果及其制备方法 | |
CN104920825A (zh) | 母猪产后的饲料添加剂及其生产方法 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN103027142A (zh) | 一种莞香花茶及其制作工艺 | |
KR20130109687A (ko) | 민물고기 어죽(魚粥)의 제조방법 및 이에 의해 제조된 민물고기 어죽 | |
CN108813501B (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN104825376A (zh) | 一种面膜洁颜粉及其制备方法 | |
CN107518132A (zh) | 一种清肝明目花茶及其制备方法 | |
CN106387178A (zh) | 具有清热解毒、健脾祛湿功效的油茶及其制备方法 | |
KR100780552B1 (ko) | 한약재를 포함한 영·유아용 기능성 분유 및 그 제조방법 | |
CN102835534A (zh) | 一种复方人参黑银杏果仁夹心巧克力的制备方法 | |
CN105558838A (zh) | 一种多味黑豆及其制备方法 | |
KR101783549B1 (ko) | Dha 함유 피로회복 증진 보조식품용 조성물 수능단(수능원) 및 그 제조방법 | |
CN104586977A (zh) | 苦丁茶颗粒剂及其生产方法 | |
KR102151925B1 (ko) | 총명 쿠키제조방법 및 이에 의해 제조된 쿠키 | |
CN108419869A (zh) | 一种清热排毒下火的组合物、饮料及其制备方法 | |
CN103444933B (zh) | 一种夏季养身中午茶袋泡茶 | |
KR100815333B1 (ko) | 한약재를 이용한 건강식품 및 그 제조방법 | |
CN111513163A (zh) | 一种用于调理湿热体质的澄明芦根茶及其制备方法 | |
KR20210041387A (ko) | 갈화 추출물 및 차전자피 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
KR20090014254A (ko) | 달콤한 미나리 침출 및 액상 차 조성물과 그 제조방법 | |
CN105362132A (zh) | 一种保健洗液 | |
CN108651777A (zh) | 一种甘薯保健饮料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181016 |
|
WW01 | Invention patent application withdrawn after publication |